Apremilast, An Oral Phosphodiesterase 4 Inhibitor, In Patients With Psoriatic Arthritis: Pharmacodynamic Results Of A Phase 3, Randomized, Controlled Trial (Palace 1)
ANNALS OF THE RHEUMATIC DISEASES（2014）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined